Rosiglitazone is effective and well tolerated in patients ≥65 years with type 2 diabetes

被引：0
|
作者：
Beebe, K
Patel, J
机构：
来源：
DIABETES | 1999年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0479
引用
收藏
页码：A111 / A111
页数：1
相关论文
共 50 条
  • [41] Rosiglitazone/Metformin (RSG/MET) fixed dose combination (FDC) is effective and well-tolerated in drug-naive type 2 diabetes, mellitus (T2DM) subjects with severe hyperglycemia
    Rosenstock, J
    Strow, L
    Rood, J
    Huang, C
    Biswas, N
    Cobitz, AR
    Davies, MJ
    DIABETES, 2005, 54 : A127 - A127
  • [42] Rosiglitazone or pioglitazone in type 2 diabetes?
    de Vries, Corinne S.
    Russell-Jones, David L.
    BRITISH MEDICAL JOURNAL, 2009, 339
  • [43] Sitagliptin Improved Glycemic Control and Was Well Tolerated When Added to Voglibose Monotherapy in Patients with Type 2 Diabetes
    Tajima, Naoko
    Kadowaki, Takashi
    Suzuki, Hideyo
    Sato, Asako
    Okuyama, Kotoba
    Minamide, Toshiomi
    Arjona Ferreira, Juan Camilo
    DIABETES, 2010, 59 : A157 - A157
  • [44] Addition of Sitagliptin Improved Glycemic Control and Was Well Tolerated in Japanese Patients with Type 2 Diabetes on Glinides Monotherapy
    Tajima, Naoko
    Kadowaki, Takashi
    Odawara, Masato
    Minamide, Toshiomi
    Seki, Akiteru
    Oki, Kaori
    Narita, Hirohisa
    Gantz, Ira
    DIABETES, 2014, 63 : A268 - A268
  • [45] Rosiglitazone for type 2 diabetes mellitus
    Richter, B.
    Bandeira-Echtler, E.
    Bergerhoff, K.
    Clar, C.
    Ebrahim, S. H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (03):
  • [46] Nine weeks of diazoxide in combination with bedtime insulin is well tolerated and β-cell beneficial in patients with type 2 diabetes
    Qvigstad, E
    Kollind, M
    Grill, V
    DIABETES, 2002, 51 : A132 - A132
  • [47] Rosiglitazone monotherapy and Type 2 diabetes
    Lawrence, IG
    DIABETIC MEDICINE, 2001, 5 : 6 - 8
  • [48] Rosiglitazone and type 2 diabetes mellitus
    Bragg, T
    LANCET, 2001, 357 (9266): : 1451 - 1451
  • [49] Diamicron®MR once daily is effective and well tolerated in type 2 diabetes -: A double-blind, randomized, multinational study
    Drouin, P
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2000, 14 (04) : 185 - 191
  • [50] Rosiglitazone for type 2 diabetes mellitus
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1999, 41 (1059): : 71 - +
12345